Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B

Eur J Clin Microbiol Infect Dis. 2002 Aug;21(8):632-4. doi: 10.1007/s10096-002-0781-6. Epub 2002 Aug 15.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Amphotericin B / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Caspofungin
  • Drug Therapy, Combination
  • Echinocandins
  • Fatal Outcome
  • Female
  • Humans
  • Lipopeptides
  • Mucormycosis / drug therapy*
  • Mucormycosis / microbiology
  • Mucormycosis / surgery
  • Peptides*
  • Peptides, Cyclic*
  • Rhizopus / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides
  • Peptides, Cyclic
  • Amphotericin B
  • Caspofungin